First Eagle Investment Management
ONCY icon

First Eagle Investment Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

First Eagle Investment Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-188,600
Closed -$243K – 359
2014
Q2 		$243K Sell
188,600
-238,600
-56% -$342K ﹤0.01% 256
2014
Q1 		$773K Hold
427,200
– – ﹤0.01% 219
2013
Q4 		$662K Hold
427,200
– – ﹤0.01% 229
2013
Q3 		$1.04M Sell
427,200
-22,800
-5% -$63.1K ﹤0.01% 215
2013
Q2 		$1.3M Buy
+450,000
New +$1.24M ﹤0.01% 234

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

First Eagle Investment Management's ONCY Position: Q3 2014 in Review

First Eagle Investment Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2014, closing a stake of 188,600 shares — an estimated $243K sold.

First Eagle Investment Management first reported a position in ONCY in Q2 2013 and held it in 5 quarters. The position peaked at $1.3M in Q2 2013. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

  • First Eagle Investment Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2014 after selling out during the quarter.
  • First Eagle Investment Management sold 188,600 ONCOLYTICS BIOTECH INC shares in Q3 2014, an estimated $243K.
  • First Eagle Investment Management first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 5 quarters.
  • First Eagle Investment Management's ONCOLYTICS BIOTECH INC position peaked at $1.3M in Q2 2013.
  • 30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on First Eagle Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.